Immunohistochemical demonstration of p53 protein and metallothioneins in canine mammary tumours

Revue de Medecine Veterinaire

Volumn 160, Issue 6, 2009, Pages 300-307

  Vural, S A ^a   Vural, M R ^a   Kuplulu, S ^a   Alcigir, M E ^a   Kaymaz, M ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Dog; Immunohistochemistry; Mammary gland; Metallothionein; P53 protein; Tumour

Indexed keywords

CANIS FAMILIARIS;

EID: 68249153599     PISSN: 00351555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. ALBARIC O., BRET L., AMARDEIHL M., DELVERDIER M.: Immunohistochemical expression of p53 in animal tumors: A methodological study using four anti-human p53 antibodies. Histol. Histopathol., 2001, 16, 113-121.
2. - BARNES D. M., DUBLIN E. A., FISHER C. J., LEVISON D. A., MILLIS R. R.: Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis? Human Pathol., 1993, 24, 469-476.
3. BIER B., DOUGLAS-JONES A., TÖTSCH M., DOCKHORN-DWORNICZACK B., BÖCKER W., JASANI B., SCHMID K. W.: Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions. Breast Cancer Res. Treat., 1994, 30, 213-221.
4. - BOSARI S., VIALE G., RONCALLI M., GRAZIANI D., BORSANI G., LEE A. K., COGGI G.: p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am. J. Pathol., 1995, 147, 790-798.
5. - CANMAN C. E., KASTMAN M. B.: Role of p53 in apoptosis, in Apoptosis: pharmacological implications and their therapeutic opportunities. Adv. Pharmacol., 1997, 41, 429-460.
6. - CHUBATSU L. S., MENEGHINI R: Metallothionein protects DNA from oxidative damage. Biochem. J., 1983, 291, 193-198.
7. rd edition., Pennsylvania, WB Saunders Co, 1994, 200-235.
8. - DAVIDOFF A. M., HUMPHREY P. A., IGLEHART J. D., MARKS J. R.: Genetic basis for p53 overexpression in human breast cancer. Proc. Natl. Acad. Sci. USA., 1991, 88, 5005-5010.
9. - DE LEO A. B., JAY G., APPELLA E., DU BORS G. C., LAW L. W., OLD L. J.: Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc. Natl. Acad. Sci. USA., 1979, 76, 2420-2424.
10. - DINCER Z., JASANI B., HAYWOOD S., MULLENS J. E., FUEN-TEALBA I. C.: Metallothionein expression in canine and feline mammary and melanotic tumours. J. Comp. Pathol., 2001, 125, 130-136.
11. - DOUGLAS-JONES A. G., SCHMID K. W., BIER B., HORGAN K., LYONS K., DALLIMORE N. D., MONEYPENNY I. J., JASANI B.: Metallothionein expression in duct carcinoma in situ of the breast. Human Pathol., 1995, 26, 217-222.
12. - FIDLER I. J., BRODEY S. R.: A necropsy study of canine malign mammary neoplasm. J. Am. Vet. Med. Assoc, 1967, 151, 710-715.
13. - FINLAY C. A., HINDS P. W., TAN T. H., ELIYAHU D., OREN M., LEVINE A. J.: Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life, Mol. Cell. Biol., 1988, 8, 531-539.
14. - GAMBLIN R. M., SAGARTZ J. E., COUTO C. G.: Overexpression of p53 tumor suppressor protein in spontaneously arising neoplasm of dogs. Am. J. Vet. Res., 1997, 58, 857-863.
15. - GILBERTSON S. R., KURZMAN I. D., ZACHRAU R. E., HUR-VITZ A. I., BLACK M. M.: Mammary epithelial neoplasms: Biologic implications of morphologic characteristics assessed in 232 dogs. Vet. Pathol., 1983, 20, 127-142.
16. - HAGA S., NAKAYAMA M., TATSUMI K., MAEDA M., IMAI S., UMESAKO S., YAMAMOTO H., HILGERS J., SARKAR N. H.: Overexpression of the p53 gene product in canine mammary tumors. Oncol. Repr., 2001, 8, 1215-1219.
17. HAINAUT P., SOUSSI T., SHOMER B., HOLLSTEIN M., GREENBLATT M., HOVIG E., HARRIS C, MONTESANO R.: Database of p53 gene somatic mutations in human tumors and cell lines: Updated compilation and future prospects. Nucl. Acids Res., 1997, 25, 151-157.
18. - HAMPE J. F., MISDORP W.: Tumours and dysplasias of the mammary gland. Bull. WHO, 1974, 50, 111-134.
19. rd edn., FOSSUN T. W. (Ed.), China, Mosby-Elsevier, 2007: 729-735.
20. - INOUE M., SHIRAMIZU K.: Immunohistochemical detection of p53 and c-myc proteins in canine mammary tumors. J. Comp. Pathol., 1999, 120, 169-175.
21. - JASANI B., SCHMID K. W.: Significance of metallothionein overexpression in human tumours. Histopathol., 1997, 31, 211-214.
22. JASANI B., CAMPBELL F., NAVABI H., SCHMID K. W., WILLIAMS G. T.: Clonal overexpression of metallothionein is induced by somatic mutation in morphologically normal colonic mucosa. J. Pathol. 1998, 184, 144-147.
23. - KAGI J. H. R.: Overview of metallothionein. Methods Enzymol., 1991, 205, 613-626.
24. - KANAYA N., OKUDA M., TOYAMA N., OIKAWA T., INOKUMA H., MORIMOTO M., HAYASHI T., UNE S., NAKAICHI M., TAURA Y., TSUJIMOTO H., ONISHI T.: Detection of the anti-p53 antibodies in dogs with tumors. J. Vet. Med. Sci., 2002, 64, 973-979.
25. - KARAYANNOPOULOU M., KALDRIMIDOU E., DESSIRIS A.: Some epidemiological aspects of canine mammary tumours treatment and prognosis. Bull. Hel. Vet. Med. Soc, 1989, 40, 111-121.
26. - KOUTSELINI H., MALLIRI A., FIELD J. K., SPANDIDOS D. A.: p53 expression in cytologic specimens from benign and malignant breast lesions. Anticancer Res., 1991, 11, 1415-1419.
27. - LEE C. H., KIM W. H., LIM J. H., KANG M. S., KIM D. Y., KWEON O. K.: Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors. J. Vet. Sci., 2004, 5, 63-69.
28. - MACEWEN E. G.: Spontaneous tumors in dogs and cats: Models for the study of cancer biology and treatment. Cancer Metas. Rev., 1990, 9, 125-136.
29. - MAYR B., REIFINGER M., ALTON K.: Novel canine tumor suppressor gene p53 mutations in cases of skin and mammary neoplasm. Vet. Res. Comm., 1999, 23, 285-291.
30. - MCCLUGGAGE W. G., MAXWELL P., HAMILTON P. W., JASANI B.: High metallothionein expression is associated with features predictive of aggressive behaviour in endometrial carcinoma. Histopathol., 1999, 34, 51-55.
31. - MENDOZA S., KONISHI T., DERNELL W. S., WITHROW S J., MILLER C. W.: Status of the p53, Rb and MDM2 genes in canine osteosarcoma. Anticancer Res., 1998, 18, 4449-4453.
32. MOMAND J., ZAMBETTI J. P., OLSON D. C., GEORGE D., LEVINE A J.: The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 1992, 69, 1237-1245.
33. rd edition., MOULTON J. E (Ed.), California, University of California Press, 1990, 518-549.
34. - NAKOPOULOU L. L., ALEXIADOU A., THEODOROPOULOS G. E., LAZARIS A. C., TZONOU A., KERAMOPOULUS A.: Prognostic significance of the co-expression of p53 and c-erB-2 proteins in breast cancer. J. Pathol., 1996, 179, 31-38.
35. - OFNER D., MAIER H., RIEDMANN B., BAMMER T., RUMER A., WINDE G., BÖCKER W., JASANI B., SCHMID K. W.: Immunohistochemical metallothionein expression in colorectal adenocarcinoma: Correlation with tumor stage and patient survival. Virch. Arch., 1994, 425, 491-497.
36. - OKUDA M., UMEDA A., SAKAI T., OHASHI T., MOMOI Y., YOUN H. Y., WATARI T., GOITSUKA R., TSUJIMOTO H., HASEGAWA A.: Cloning of feline p53 tumor-suppressor gene and its aberration in hematopoietic tumors. Int. J. Cancer, 1994, 58, 602-607.
37. - OWEN L. N.: The T. N. M.: Classification of tumors in domestic animals. WHO., OWEN L. N (Ed), Geneva, 1980, 20-80.
38. - OYAMA T., TAKEI H., HIKINO Y., LINO Y., NAKAJIMA T.: Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis. Oncology, 1996, 53, 112-117.
39. - OZBUN M. A., BUTEL J. S.: p53 tumor suppressor gene: structure and function. In: Encyclopedia of cancer. Vol. II. BERTINO J. R. (ed.). Academic Press. San Diego. 1997, pp 1240-1257.
40. PAMUKCU M., ERTURK E.: Ankara'da Köpeklerde Görölen Tümör Çeşitleri. Ank. Üni. Vet. Fak. Derg., 1962, 9, 1-9.
41. - POLLER D. N., ROBERTS E. C., BELL J. A., ELSTON J. W., BLAMEY R. W., ELLIS I. O.: p53 protein expression in mammary ductal carcinoma in-situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein. Human Pathol., 1993, 24, 463-468.
42. - RUNGSIPIPAT A., TATEYAMA S., YAMAGUCHI R., UCHIDA K., MIYOSHI N., HAYASHI T.: Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors. J. Vet. Med. Sci., 1999, 61, 27-32.
43. - RUTTEN V. P., MISDORP W., GAUTHIER A., ESTRADA M., MIALOT J. P., PARODI A. L., RUTTEMAN G. R., WEYER K.: Immunological aspects mammary tumors in dogs and cats: A survey including own studies and pertinent literature. Vet. Immunol. Immunopathol., 1990, 26, 211-225.
44. - RYAN J. J., PROCHOWNIK E., GOTTLIEB C. A., APEL I. J., MERINO R., NUMEZ G., CLARKE M. F.: c-myc and bc12 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc. Natl. Acad. Sci. USA, 1994, 91, 5878-5882.
45. - SAGARTZ J. E., BODLEY W. L., GAMBLIN R. M., COUTO C. G., TIERNEY L. A., CAPEN C. C.: p53 tumor suppressor protein overexpression in osteogenic tumors of dogs. Vet. Pathol., 1996, 33, 213-221.
46. - SAWAKI M., ENOMOTO K., HATTORI A.. TSUZUKI N., SAWADA N., MORI M.: Elevation of metallothionein level in preneoplastic lesions during chemical hepatocarcinogenesis of the Fischer 344 Rat. Toxicol. Lett., 1999, 108, 55-61.
47. - SCHAFER K. A., KELLY G., SCHRADER R., GRIFFITH W. C., MUGGENBURG B. A., TIERNEY L. A., LECHNER J. F., JANOVITZ E. B., HAHN F. F.: A canine model of familial mammary gland neoplasia. Vet. Pathol., 1998, 35, 168-177.
48. - SCHMID K. W., ELLIS I. O., GEE J. M. W., DARKE B. M., LEES W. E., KAY J., CRYER A., STARK J. M., HITTMAIR A., ÖFNER D., DÜNSER M., MARGREITER R., DAXENBICHLER G., NICHOLSON R. I., BIER B., BÖCKER W., JASANI B.: Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast. Virch. Arch. A. Pathol. Anat., 1993, 422, 153-159.
49. - SIRONI G., RICCABONI P., MERTEL L., CAMMARATA G., BROOKS D. E.: p53 protein expression in conjunctival squamous cell carcinomas of domestic animals, Vet. Ophtalmol., 1999, 2, 227-231.
50. - TEIFKE J. P., LOHR C. V.: Immunohistochemical detection of p53 overexpression in paraffin wax-embedded squamous cell carcinomas of cattle, horses, cats, and dog. J. Comp. Pathol., 1996, 114, 205-210.
51. - VAN LEEUWEN I. S., CORNELISSE C. J., MISDORP W., GOEDEGEBUURE S. A., KIRPENSTEIJN J., RUTTEMAN G. R.: p53 gene mutations in osteosarcomas in the dog. Cancer Lett., 1997, 111, 173-178.
52. - WOLF J. C., GINN P. E., HOMER B., FOX L. E., KURZMAN I. D.: Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors. Vet. Pathol., 1997, 34, 394-404.
53. - YAMAMURA Y., SAYAMA K., TAKEDA Y., MATSUZAWA A., IGUCHI T., OHTA Y.: Metallothionein expression in transplantable mouse mammary tumors. Anticancer Res., 2000, 20, 379-384.
54. - YONISH-ROUACH E., RESNITZKY D., LOTEM J., SACHS L., KIMCHI A. M., OREN M.: Wild-Type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature, 1991, 352, 345-347.
55. - ZACCHETTI A., VAN GARDEREN E., RUTTEMAN G. R.: Immunohistochemical evaluation of p53 expression with different antibodies in malignant canine tumors with or without p53 gene mutation. Vet. Comp. Oncol., 2007, 5, 108-118.
56. - ZENG J., HEUCHEL R., SCHAFFNER W., KAGI J. H. R.: Thionein (Apometallothionein) can modulate DNA binding and transcription activation by zinc finger containing factor Spl. FEBS Lett., 1991, 279, 310-312.